Deva Holding

DEVA

TRADEVAW91E2

Pharmaceuticals

Market Closed - Borsa Istanbul Other stock markets 11:08:03 2024-05-13 am EDT			5-day change	1st Jan Change
75.95 ^TRY	-2.38%		-2.00%	+0.53%

Feb. 12	Tod's rises 17% on L Catterton bids to help owner's delisting plan	RE
2023	Deva Holding A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Deva Holding A.S.(IBSE:DEVA) added to S&P Global BMI Index

September 21, 2020 at 12:00 am EDT

Latest news about Deva Holding

Tod's rises 17% on L Catterton bids to help owner's delisting plan	Feb. 12	RE
Deva Holding A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 03	CI
Deva Holding A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI
Deva Holding A.S. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05	CI
Deva Holding A.S. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10	CI
Deva Holding A.S. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10	CI
Deva Holding A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-04	CI
Deva Holding A.S.(IBSE:DEVA) dropped from S&P Global BMI Index	22-09-19	CI
Deva Holding A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Deva Holding A.S. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-06	CI
Deva Holding A.S. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-04	CI
Deva Holding A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-05	CI
Deva Holding A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI
Deva Holding A.S. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-07	CI
Deva Holding A.S. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-05	CI
Deva Holding A.S. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-06	CI
Deva Holding A.S.(IBSE:DEVA) added to S&P Global BMI Index	20-09-21	CI
Deva Holding A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-14	CI
Deva Holding A.S. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-08	CI
Deva Holding A.S. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-06	CI
Deva Holding A.S. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-08	CI
Deva Holding A.S.(IBSE:DEVA) added to Istanbul Stock Exchange National 100 Index	19-10-01	CI
Deva Holding A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-19	CI
Deva Holding A.S. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-10	CI
Deva Holding A.S. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended Sep, 30, 2017	17-11-01	CI

Deva Holding AS is a Turkey-based pharmaceutical company that is primarily engaged in the production and marketing of finished pharmaceutical products, pharmaceutical ingredients and veterinary products, as well as animal health products, among others. The Company has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Companyâs product portfolio comprises 73 drugs, which are available on the market in 177 various forms. It offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The Company has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DEVA HOLDING	+0.53%	483M
ELI LILLY AND COMPANY	+29.98%	684B
NOVO NORDISK A/S	+30.34%	568B
JOHNSON & JOHNSON	-3.52%	361B
MERCK & CO., INC.	+18.59%	329B
ABBVIE INC.	+4.07%	284B
ASTRAZENECA PLC	+16.21%	240B
NOVARTIS AG	+9.66%	208B
ROCHE HOLDING AG	-6.83%	200B
AMGEN INC.	+7.09%	166B

Other Pharmaceuticals

Deva Holding

Equities

DEVA

TRADEVAW91E2

Pharmaceuticals

Deva Holding A.S.(IBSE:DEVA) added to S&P Global BMI Index

Latest news about Deva Holding

Chart Deva Holding

Company Profile

Income Statement Evolution

Sector Other Pharmaceuticals